Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Ms. Snizhana QuanVP of Finance, Corporate Controller, Principal Financial Officer & Principal Accounting Officer | -345,00 | 3,94k | Vendita | 11,41 | 27,19k | -1,25% |
| 2026-04-28 | Mr. Ronald A. BucchiNon-Executive Independent Chairman | -100,00k | 0,00 | Other Disposition | - | 197,88k | -33,57% |
| 2026-04-10 | Ms. Snizhana QuanVP of Finance, Corporate Controller, Principal Financial Officer & Principal Accounting Officer | -20,00k | 109,80k | Derivative Exercise and Sale | 4,87 - 10,36 | 55,93k | - |
| 2026-04-01 | Dr. Craig CieslaIndependent Director | -11,00k | 74,91k | Vendita | 6,81 | 118,82k | -8,47% |
| 2026-04-07 | Mr. Siraj Nour El-AhmadiDirector | -34,38k | 266,75k | Vendita | 7,76 | 97,17k | -26,13% |
| 2026-03-31 | Mr. Siraj Nour El-AhmadiDirector | -20,16k | 156,45k | Derivative Exercise and Sale | 7,76 | 97,17k | - |
| 2026-04-06 | Dr. Thomas Martin ConnellyIndependent Director | -9,00k | 76,68k | Vendita | 8,52 | 77,13k | -10,45% |
| 2026-03-31 | Dr. Thomas Martin ConnellyIndependent Director | 20,16k | 0,00 | Derivative Exercise and Retained Stock | - | 86,13k | 30,56% |
| 2026-03-31 | Dr. Craig CieslaIndependent Director | 20,16k | 0,00 | Derivative Exercise and Retained Stock | - | 129,82k | 18,38% |
| 2026-03-31 | Mr. Ronald A. BucchiNon-Executive Independent Chairman | -11,00k | 76,12k | Derivative Exercise and Sale | 6,92 | 297,88k | - |
| 2026-03-31 | Mr. Ronald A. BucchiNon-Executive Independent Chairman | 9,16k | 0,00 | Derivative Exercise and Retained Stock | - | 297,88k | 3,17% |
| 2026-03-31 | Ms. Laila S. PartridgeIndependent Director | -11,00k | 75,24k | Derivative Exercise and Sale | 6,84 | 80,72k | - |
| 2026-03-31 | Ms. Laila S. PartridgeIndependent Director | 9,16k | 0,00 | Derivative Exercise and Retained Stock | - | 80,72k | 12,80% |
| 2026-03-30 | Ms. Snizhana QuanVP of Finance, Corporate Controller, Principal Financial Officer & Principal Accounting Officer | -25,00k | 60,00k | Derivative Exercise and Sale | 4,87 - 7,27 | 27,53k | - |
| 2026-03-12 | Mr. Yves LeMaitrePresident, CEO & Employee Director | -294,97k | 2,09M | Sale to Issuer | 7,08 | 378,71k | -43,79% |
| 2026-01-27 | Mr. Siraj Nour El-AhmadiDirector | 24,41k | 16,60k | Derivative Exercise and Retained Stock | 0,68 | 123,94k | 24,52% |
| 2026-01-27 | Mr. Siraj Nour El-AhmadiDirector | -25,59k | 71,65k | Derivative Exercise and Sale | 0,68 - 3,48 | 123,94k | - |
| 2026-01-23 | Mr. Ronald A. BucchiNon-Executive Independent Chairman | 50,00k | 34,00k | Derivative Exercise and Retained Stock | 0,68 | 258,74k | 23,95% |
| 2025-12-31 | Mr. Siraj Nour El-AhmadiDirector | -20,16k | 63,53k | Derivative Exercise and Sale | 3,15 | 99,54k | - |
| 2025-12-31 | Mr. Siraj Nour El-AhmadiDirector | -29,10k | 91,69k | Vendita | 3,15 | 99,54k | -22,62% |
| 2025-12-31 | Dr. Thomas Martin ConnellyIndependent Director | 12,56k | 0,00 | Derivative Exercise and Retained Stock | - | 58,37k | 27,42% |
| 2025-12-31 | Dr. Thomas Martin ConnellyIndependent Director | -7,60k | 24,70k | Derivative Exercise and Sale | 3,25 | 58,37k | - |
| 2025-12-31 | Mr. Ronald A. BucchiNon-Executive Independent Chairman | 20,16k | 0,00 | Derivative Exercise and Retained Stock | - | 208,74k | 10,69% |
| 2025-12-31 | Ms. Laila S. PartridgeIndependent Director | 10,16k | 0,00 | Derivative Exercise and Retained Stock | - | 63,96k | 18,89% |
| 2025-12-31 | Ms. Laila S. PartridgeIndependent Director | -10,00k | 37,20k | Derivative Exercise and Sale | 3,72 | 63,96k | - |
| 2025-12-31 | Dr. Craig CieslaIndependent Director | 20,16k | 0,00 | Derivative Exercise and Retained Stock | - | 102,06k | 24,62% |
| 2025-12-31 | Mr. James S. MarcelliInsider | -77,76k | 251,94k | Sale to Issuer | 3,24 | 868,29k | -8,22% |
| 2025-12-31 | Rear Admiral Thomas E. ZeliborInsider | -70,73k | 229,17k | Sale to Issuer | 3,24 | 386,72k | -15,46% |
| 2025-09-30 | Dr. Thomas Martin ConnellyIndependent Director | 14,16k | 0,00 | Derivative Exercise and Retained Stock | - | 45,81k | 44,74% |
| 2025-09-30 | Dr. Thomas Martin ConnellyIndependent Director | -6,00k | 25,53k | Derivative Exercise and Sale | 4,26 | 45,81k | - |
| 2025-09-30 | Mr. Siraj Nour El-AhmadiDirector | 20,16k | 0,00 | Derivative Exercise and Retained Stock | - | 128,63k | 18,59% |
| 2025-09-30 | Mr. Ronald A. BucchiNon-Executive Independent Chairman | 10,16k | 0,00 | Derivative Exercise and Retained Stock | - | 188,58k | 5,69% |
| 2025-09-30 | Mr. Ronald A. BucchiNon-Executive Independent Chairman | -10,00k | 39,67k | Derivative Exercise and Sale | 3,97 | 188,58k | - |
| 2025-09-30 | Ms. Laila S. PartridgeIndependent Director | 10,16k | 0,00 | Derivative Exercise and Retained Stock | - | 53,80k | 23,28% |
| 2025-09-30 | Ms. Laila S. PartridgeIndependent Director | -10,00k | 41,14k | Derivative Exercise and Sale | 4,11 | 53,80k | - |
| 2025-09-30 | Dr. Craig CieslaIndependent Director | 20,16k | 0,00 | Derivative Exercise and Retained Stock | - | 81,90k | 32,65% |
| 2025-07-15 | Mr. Ronald A. BucchiNon-Executive Independent Chairman | 20,16k | 0,00 | Derivative Exercise and Retained Stock | - | 178,42k | 12,74% |
| 2025-07-15 | Dr. Thomas Martin ConnellyIndependent Director | 20,16k | 0,00 | Derivative Exercise and Retained Stock | - | 31,65k | 175,50% |
| 2025-07-15 | Dr. Craig CieslaIndependent Director | 20,16k | 0,00 | Derivative Exercise and Retained Stock | - | 61,74k | 48,49% |
| 2025-07-15 | Mr. Siraj Nour El-AhmadiDirector | 20,16k | 0,00 | Derivative Exercise and Retained Stock | - | 108,47k | 22,83% |
| 2025-07-15 | Ms. Laila S. PartridgeIndependent Director | 20,16k | 0,00 | Derivative Exercise and Retained Stock | - | 43,64k | 85,87% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
